A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children

Magnesium, a vasodilator, anti-inflammatory, and pain reliever, could alter the pathophysiology of sickle cell pain crises. We hypothesized that intravenous magnesium would shorten length of stay, decrease opioid use, and improve health-related quality of life (HRQL) for pediatric patients hospitali...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Blood
Main Authors: Brousseau, David C., Scott, J. Paul, Badaki-Makun, Oluwakemi, Darbari, Deepika S., Chumpitazi, Corrie E., Airewele, Gladstone E., Ellison, Angela M., Smith-Whitley, Kim, Mahajan, Prashant, Sarnaik, Sharada A., Casper, T. Charles, Cook, Lawrence J., Dean, J. Michael, Leonard, Julie, Hulbert, Monica L., Powell, Elizabeth C., Liem, Robert I., Hickey, Robert, Krishnamurti, Lakshmanan, Hillery, Cheryl A., Nimmer, Mark, Panepinto, Julie A.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2015
Teme:
Clinical Trials and Observations
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4591790/
https://ncbi.nlm.nih.gov/pubmed/26232172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-05-647107
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki